Published in J Med Primatol on June 01, 1997
Allergic asthma induced in rhesus monkeys by house dust mite (Dermatophagoides farinae). Am J Pathol (2001) 1.25
TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36/AHG malaria vaccine in nonhuman primate models. Hum Vaccin Immunother (2013) 0.79
Analysis on reactivity of human lymphocyte and monocyte-specific antibodies with peripheral blood mononuclear cells from squirrel monkeys (Saimiri sciureus) J Med Primatol (1998) 0.75
Transfected Plasmodium knowlesi produces bioactive host gamma interferon: a new perspective for modulating immune responses to malaria parasites. Infect Immun (2003) 0.75
Genetic influence on cytokine production and fatal meningococcal disease. Lancet (1997) 4.89
Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites. Mol Biochem Parasitol (1994) 3.36
The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature (2008) 3.02
Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat Med (2000) 2.70
Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells. Infect Immun (2004) 2.59
The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes. Mol Biochem Parasitol (1984) 2.54
Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J Biol Chem (2001) 2.53
Precise timing of expression of a Plasmodium falciparum-derived transgene in Plasmodium berghei is a critical determinant of subsequent subcellular localization. J Biol Chem (1998) 2.44
Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection. Infect Immun (2000) 2.29
Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum (1998) 2.24
Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc Natl Acad Sci U S A (2001) 2.21
Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. falciparum AMA-1, and antibody-mediated inhibition of red cell invasion. Mol Biochem Parasitol (2000) 2.21
A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev (2001) 2.18
Origin of Plasmodium falciparum malaria is traced by mitochondrial DNA. Mol Biochem Parasitol (2000) 2.12
A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout Plasmodium. J Biol Chem (1990) 2.02
The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect Immun (1998) 2.00
Transfection of malaria parasites. Methods (1997) 1.99
Nucleotide sequences of chimpanzee MHC class I alleles: evidence for trans-species mode of evolution. EMBO J (1988) 1.98
Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin Exp Immunol (1982) 1.97
Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. J Infect Dis (1993) 1.95
The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc (2000) 1.76
High levels of interleukin 10 and tumor necrosis factor alpha in cerebrospinal fluid during the onset of bacterial meningitis. Clin Infect Dis (1995) 1.70
Nitric oxide (NO) production correlates with renal insufficiency and multiple organ dysfunction syndrome in severe sepsis. Intensive Care Med (1996) 1.49
TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol (1997) 1.43
Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine. Proc Natl Acad Sci U S A (1990) 1.39
Acute bleeding varices: a five-year prospective evaluation of tamponade and sclerotherapy. Ann Surg (1981) 1.36
A new group of hepadnaviruses naturally infecting orangutans (Pongo pygmaeus). J Virol (1999) 1.32
High-level expression of Plasmodium vivax apical membrane antigen 1 (AMA-1) in Pichia pastoris: strong immunogenicity in Macaca mulatta immunized with P. vivax AMA-1 and adjuvant SBAS2. Infect Immun (1999) 1.32
Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization. Transplant Proc (1987) 1.30
The human immunodeficiency virus type 1 nef gene can to a large extent replace simian immunodeficiency virus nef in vivo. J Virol (1999) 1.26
Genetic influence on cytokine production in meningococcal disease. Lancet (1997) 1.23
The effects of interferon beta treatment on arthritis. Rheumatology (Oxford) (1999) 1.20
Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res Hum Retroviruses (1994) 1.19
Plasmodium knowlesi: secondary processing of the malaria merozoite surface protein-1. Exp Parasitol (1996) 1.14
Experimental norovirus infections in non-human primates. J Med Virol (2005) 1.14
Transfection of the primate malaria parasite Plasmodium knowlesi using entirely heterologous constructs. J Exp Med (1997) 1.13
AIDS vaccine development in primate models. AIDS (1998) 1.12
Shared class II MHC polymorphisms between humans and chimpanzees. Hum Immunol (1989) 1.11
Speciation and intrasubspecific variation of Bornean orangutans, Pongo pygmaeus pygmaeus. Mol Biol Evol (2001) 1.11
A new reagent for the induction of T-cell depletion, anti-CD3-CRM9. J Immunother Emphasis Tumor Immunol (1996) 1.11
Increased intracellular survival of Mycobacterium smegmatis containing the Mycobacterium leprae thioredoxin-thioredoxin reductase gene. Infect Immun (1997) 1.10
The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol (1993) 1.10
Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response. J Virol (2004) 1.09
Comment on "Taming the pion cloud of the nucleon". Phys Rev Lett (2013) 1.09
Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees. J Immunol (1999) 1.07
Generation of CD8 suppressor factor and beta chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques. Proc Natl Acad Sci U S A (1998) 1.07
Experimental immune mediated arthritis in rhesus monkeys. A model for human rheumatoid arthritis? Rheumatol Int (1990) 1.07
Intrapelvic injection of menstrual endometrium causes endometriosis in baboons (Papio cynocephalus and Papio anubis). Am J Obstet Gynecol (1995) 1.06
The influence of OKT8F treatment on allograft survival in rhesus monkeys. Transplantation (1986) 1.06
Collagen-induced arthritis in an outbred group of rhesus monkeys comprising responder and nonresponder animals. Relationship between the course of arthritis and collagen-specific immunity. Arthritis Rheum (1991) 1.05
Lymphocytes are the major reservoir for foamy viruses in peripheral blood. Virology (1996) 1.05
Experimental allergic encephalomyelitis in rhesus monkeys: II. Treatment of EAE with anti-T lymphocyte subset monoclonal antibodies. Clin Exp Immunol (1987) 1.04
Malaria parasites contain two identical copies of an elongation factor 1 alpha gene. Mol Biochem Parasitol (1998) 1.04
Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo. J Infect Dis (1999) 1.04
Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region. J Exp Med (1992) 1.04
Evolutionary stability of transspecies major histocompatibility complex class II DRB lineages in humans and rhesus monkeys. Hum Immunol (1992) 1.03
Antibodies to glycans dominate the host response to schistosome larvae and eggs: is their role protective or subversive? J Infect Dis (2001) 1.03
Quantification of pain-induced changes in cerebral blood flow by perfusion MRI. Pain (2007) 1.02
Mycobacterial heat-shock protein 65 induces proinflammatory cytokines but does not activate human mononuclear phagocytes. Scand J Immunol (1994) 1.02
Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes. Mol Biochem Parasitol (1989) 1.01
Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs. Acta Neuropathol (2001) 1.00
Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge. AIDS Res Hum Retroviruses (1994) 1.00
The relative resistance of HIV type 1-infected chimpanzees to AIDS correlates with the maintenance of follicular architecture and the absence of infiltration by CD8+ cytotoxic T lymphocytes. AIDS Res Hum Retroviruses (1999) 1.00
Seroprevalence of specific viral infections in confiscated orangutans (Pongo pygmaeus). J Med Primatol (1998) 1.00
Intra-generic conservation and limited inter-strain variation in a protective minor surface antigen of Plasmodium knowlesi merozoites. Mol Biochem Parasitol (1991) 0.99
Low-intensity exercise enhances expression of markers of alternative activation in circulating leukocytes: roles of PPARγ and Th2 cytokines. Atherosclerosis (2010) 0.99
TT viruses (TTV) of non-human primates and their relationship to the human TTV genotypes. J Gen Virol (1999) 0.98
Stable expression of green fluorescent protein in blood and mosquito stages of Plasmodium berghei. Mol Biochem Parasitol (1998) 0.98
Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J Exp Med (1994) 0.98
Resistance to collagen-induced arthritis in rats and rhesus monkeys after immunization with attenuated type II collagen. Eur J Immunol (1993) 0.97
Comparative analysis of Plasmodium reichenowi and P. falciparum erythrocyte-binding proteins reveals selection to maintain polymorphism in the erythrocyte-binding region of EBA-175. Mol Biochem Parasitol (2001) 0.97
Specific passage of simian immunodeficiency virus from end-stage disease results in accelerated progression to AIDS in rhesus macaques. J Gen Virol (1999) 0.97
Expression patterns of regulatory T-cell markers in accepted and rejected nonhuman primate kidney allografts. Am J Transplant (2007) 0.96
Biosynthesis of a putative protective Plasmodium knowlesi merozoite antigen. Mol Biochem Parasitol (1984) 0.96
Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta. Virology (1997) 0.96
The human immune response to the OKT3 monoclonal antibody is oligoclonal. Science (1986) 0.95
Detection of human T-cell leukaemia virus 1 permissive cells using cell lines producing selectable recombinant virions. J Virol Methods (1994) 0.95
Collagen-induced arthritis in rhesus monkeys: evaluation of markers for inflammation and joint degradation. Br J Rheumatol (1998) 0.95
Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees. AIDS (2001) 0.95
Fatal Herpes simplex infection in a group of common marmosets (Callithrix jacchus). Vet Pathol (2003) 0.95
Differentiation antigens on rhesus monkey lymphocytes. I. Identification of T cells bearing CD3 and CD8, and of a subset of CD8-bearing cells. Eur J Immunol (1986) 0.95
Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors. Br J Pharmacol (2008) 0.95
Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor necrosis factor alpha, interleukin-1 beta (IL-1 beta), and IL-10 by human leukocytes. Clin Diagn Lab Immunol (1995) 0.95
Platynosomum fastosum in ex-captive orangutans from Indonesia. J Wildl Dis (1998) 0.95
A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection. AIDS (1998) 0.94
RFLP analysis of the rhesus monkey MHC class II DR subregion. Hum Immunol (1991) 0.94